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Abstract 
Background: Pseudomonas aeruginosa (P. aeruginosa) is one of the most important causes of infection in burns and 
intensive care units. Extended-spectrum β-lactamases (ESBLs) production in P. aeruginosa is a major factor in the 
antibiotic resistance and is thought of as a serious threat to the currently available antibiotic armory. The purpose of 
this study was to determine the prevalence of CTX-M gene in ESBL-producing P. aeruginosa isolates in burn wound 
samples. Materials and Methods: In this cross-sectional survey, a total of 60 clinical isolates of P. aeruginosa were 
obtained from patients suffering from burn wound infection referred to major hospitals of Tehran, Iran. After 
verification by biochemical tests and antimicrobial susceptibility testing, CTX-M gene was identified using PCR 
method. Results: The results of the molecular analysis of CTX-M gene showed that the prevalence of isolates of P. 
aeruginosa harboring CTX-M gene was 20% (12/60). Conclusion: The results from this study showed high levels of 
antibiotic resistance and CTX-M gene among P. aeruginosa isolated samples of burn-wound infections which 
condition may result in the increased the emergence of multidrug-resistant strains and the failure of therapy This 
study suggests that detailed data on the CTX-M gene frequency can be useful to achieve the best therapy for 
infections caused by ESBLs producing P. aeruginosa. 
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     Pseudomonas aeruginosa (P. aeruginosa) is 
an opportunistic bacterial pathogen, considered as one 
of the main causes of death and morbidity in burn 
wards (1-3). Treatment of burn wound infection 
caused by P. aeruginosa is becoming difficult, due to 
its notable intrinsic mechanisms of resistance (4). One 
of the most common drug resistance mechanisms is 
the production of Extended–Spectrum Beta-
Lactamase enzymes (ESBLs) in the bacteria. The 
ESBLs consist of a heterogeneous molecular cluster 
of plasmid-mediated bacterial enzymes that indicate 
substantial resistance to oxyimino-cephalosporin and 
monobactam antimicrobials, but they cannot 
hydrolyze carbapenemases or cephamycins (5, 6). 
Pathogenic strains of P. aeruginosa produce 
three main classes of ESBLs: TEM, SHV, and CTX-
M (6-8). In the 1990s, ESBL-producing bacteria were 
defined essentially as closely related components of 
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the TEM and SHV-β-lactamase families, in Klebsiella 
pneumonia and Escherichia coli causing outbreaks of 
nosocomial infection (6, 9). One of the most 
important enzymes is the CTX-M, which stands for 
'active on cefotaxime, first isolated in Munich' and 
reflects the potent hydrolytic activity of the enzyme 
against cefotaxime (10). CTX-M gene has 
disseminated among a wide range of clinical bacteria 
within and across the species in the world since 1995 
(11).  
ESBLs producing P. aeruginosa has become a 
major global challenge in burn research and 
management and there is ample evidence regarding 
the prevalence of ESBLs in the range of 6 ‒ 88% in 
health care centers around the world (6). Furthermore, 
systemic infections induced by ESBL producing P. 
aeruginosa are linked to higher healthcare costs, 
severe adverse clinical consequences, and mortality 
(7, 12). Given these, the rapid increase of ESBL-
producing P. aeruginosa in hospital-acquired 
infections is now a serious concern for the therapeutic 
development for infection by resistant bacterial 
pathogens (13). 
Knowledge on antibiotic resistance patterns 
and the frequency of CTX-M gene between P. 
aeruginosa isolated samples in different regions could 
help in the selection of antimicrobial therapy and 
improve the outcome of infections. With this 
background, the aim of this study was to determine 
the prevalence of the ESBL phenotype and CTX-M 
gene in P. aeruginosa isolated from patients suffering 
from burn wound infection in Tehran, Iran. 
 
Methods 
Isolation of bacteria. A total of 60 consecutive 
multidrug-resistant P. aeruginosa isolates were 
obtained from different burn wards in affiliated 
hospitals in Tehran city, Iran, in the years 2016 and 
2017. The isolates were detected as P. aeruginosa by 
the standard bacteriological methods and biochemical 
testing including oxidase tests, H2S production, 
movement, indole production, urease, culturing in 
agar starter and Tsi and carbohydrate fermentation. 
The isolates were stored at −20 °C in the media 
containing Tryptic Soy Broth (TSB) medium with 
10% glycerol. 
Extraction of plasmid DNA of ESBL 
producing Pseudomonas aeruginosa. Pure colonies 
of freshly bacteria were inoculated into 2 ml of Luria 
Bertani medium containing 100 μg ampicillin in 
sterile conditions. The tubes were inseminated after 
incubation at 37 ° C at 170 rpm for 15 hours. Plasmid 
DNA was isolated from bacterial cells using SinaClon 
Preps kit (Cat. No: PR881612) according to the 
company's instructions. The purified plasmid was 
stored at -20°C.  
CTX-M gene detection using Polymerase 
Chain Reaction (PCR). Polymerase chain reaction 
(PCR) was performed to amplify type-specific CTX-
M gene. 10 μl of DNA template used in the PCR 
reaction containing a 1X buffer, MgCl2, dNTP, Taq 
polymerase, and primers for detection of the CTX-M 





The PCR conditions for amplification of the CTX-M 
gene were done as follows: Initial denaturation at 95 
°C for 3 minutes, denaturation at 95 °C for 30 
seconds, 30 seconds for annealing at 55 °C, 1 minute 
at 72 °C for elongation, and the final extension was 
conducted at 72 °C for 10 minutes. A negative control 
was used in every PCR assay. The amplified products 
were analyzed after electrophoresis in 1.5% agarose 
gel at 120 V, for 35 minutes. The gel was visualized 
by staining with ethidium bromide and a100 ‒5000 bp 
ladder molecular weight marker (Fermentas, Vilnius, 
Lithuania) was used. The images of stained DNA 
bands were documented using the UV gel 
documentation system. 
Statistical analysis. Statistical analysis was 
performed by the Chi-Square test (χ2) using SPSS 
version 18 (SPSS Inc., Chicago, IL, USA). All values, 
in which the probability of the null hypothesis was P 
≤ 0.05, were regarded as statistically significant. 
Ethical Considerations. The present study was 
accepted by the ethics committees of the Islamic Azad 
University, Central Tehran Branch, Iran. Written 
informed consents were obtained from all the study 
patients or their parents. 
Results 
During the study period, 60 clinical isolates 
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were isolated consecutively from wounds at burn 
wards. The ESBL-producing P. aeruginosa were 
subjected to PCR using CTX-M specific primers. Of 
the ESBL-producing P. aeruginosa isolates 12 (20%) 
were positive for ESBL genes and 48 isolates (80%) 
were negative. The results of PCR-products 
electrophoresis indicated genomic patterns related to 
CTX-M (593 bp) (Figure 1). 
Discussion 
Burn-wound infectious complications are the 
important causes of death and morbidity in serious 
thermal injuries. The most common agents 
responsible for burn-wound infections are bacteria, 
with P. aeruginosa being the most important species 
(14-16). Increasingly, resistance to antimicrobials 
among the bacteria causing the infections, practically 
P. aeruginosa, has limited treatment choices. The 
prevalence of ESBL among clinical isolates of P. 
aeruginosa impressively varies between geographical 
areas and is changing rapidly with time. Therefore, 
identification of beta-lactamase is critical for a 
reliable molecular epidemiological analysis of 
antimicrobial resistance (17-19). On the other hand, 
insights into local antimicrobial resistance trends 
among isolated samples are important for evidence-
based recommendations in the empirical antibiotic 
therapy of the infections (6).  
Due to the important role of P. aeruginosa in 
burn wound infections and the necessity of 
identifying antibiotic resistance patterns the CTX-M 
gene was identified by PCR. High prevalence of 
ESBL-producing P. aeruginosa within our population 
might be caused by the extensive use of third 
generation cephalosporins in hospitals.As mentioned, 
the distribution and occurrence of ESBL vary greatly 
worldwide among different species and countries 
(20). Our findings indicate that CTX-M type β-
lactamases are prevalent in the studied population (20 
%). We figured out the higher prevalence of CTX-M 
type β-lactamase than that described in countries such 
as China (2). Similar results were reported in Brazil 
(21) (19.6%), Iran (in a different area) (22) (17.3%) 
and Saudia Arabia (23) (22.4%) of P. aeruginosa. 
High levels of antibiotic resistance in ESβL-
producing P. aeruginosa in clinical isolates of burn 
wounds is alarming (24). ESBLs enzymes, especially 
CTX-M, have increased sharply in recent years as 
showed in the review of Paterson and Bonomo (7). 
Consistent with findings of recent studies by other 
researchers, it can be concluded that the excessive use 
of antibiotics causes the higher percentage of drug-
resistance in ESβL-producing P. aeruginosa and leads 
to the transmission of the resistance genes through the 
pathogenic bacteria more quickly. In the current 
study, the frequency of the β-lactamase enzyme, 
CTX-M, was 20%, which could be a rational indicator 
for high-level resistance of isolates to third and fourth 
generation cephalosporins. 
Conclusion  
In summary, our findings indicate a high 
prevalence of CTX-M gene among the ESBL-
producing P. aeruginosa isolates obtained from burn 
wards. The evidence from this study enhanced our 
knowledge of the prevalence of ESBL enzymes and 
suggested the need for improved surveillance of 
additional ESBL, CTX-M, in ESBL-producing P. 
aeruginosa. In the case of suspected ESBLs producer 
clinical isolates of P. aeruginosa, PCR based 
molecular methods could help to detect the gene and 
the approach may help in preventing the development 
of drug resistance.  
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Figure 1. Electrophoresis of PCR products on a 1% agarose gel. 
Lane1. Ladder 100 bp. Lane 2. Positive control. Lane 3. Negative 
control. Lanes 2, 4, 7. Positive samples that indicated a 593 bp 
PCR product. 
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